The outcome of allogeneic hematopoietic stem cell transplantation (allo-HSCT) patients has
significantly improved over the past decade. Still, a significant number of patients require …

As outcomes have improved across the hematologic malignancy population, candidacy for
ICU admission has increased. This complex population may develop a variety of …

Objective We wished to explore the use, diagnostic capability and outcomes of
bronchoscopy added to noninvasive testing in immunocompromised patients. In this setting …

Purpose Several studies showed conflicting results about prognosis and predictors of
outcome of critically ill patients with hematological malignancies (HM). The aim of this study …

Survival of allogeneic hematopoietic stem cell transplant (aHSCT) recipients in the intensive
care unit (ICU) has been poor. We retrospectively analyzed the short-and long-term …

Pulmonary complications are a significant cause of morbidity, mortality, and resource
utilization after hematopoietic stem cell transplantation (HSCT). The objective of this study …

Objectives To evaluate the associations between early cumulative fluid balance (CFB) and
outcomes among critically ill pediatric allogeneic hematopoietic cell transplant (HCT) …

Hematopoietic stem cell transplant (HSCT) is an essential therapeutic modality in the
treatment of malignant and nonmalignant hematologic disease. In 2018, approximately …

The utility of transbronchial biopsy in the management of pulmonary complications following
hematopoietic stem cell transplantation (HSCT) has shown variable results. Herein, we …

Plasma biomarkers associated with respiratory failure (RF) following hematopoietic cell
transplantation (HCT) have not been identified. Therefore, we aimed to validate early (7 and …